Matches in DBpedia 2014 for { ?s ?p Farletuzumab (MORAb-003) is a monoclonal antibody which is being investigated for the treatment of ovarian cancer.This drug was developed by Morphotek, Inc.It is targeted at FR-alpha which is overexpressed in some cancers such as ovarian cancer.. }
Showing items 1 to 2 of
2
with 100 items per page.
- Farletuzumab abstract "Farletuzumab (MORAb-003) is a monoclonal antibody which is being investigated for the treatment of ovarian cancer.This drug was developed by Morphotek, Inc.It is targeted at FR-alpha which is overexpressed in some cancers such as ovarian cancer.".
- Farletuzumab comment "Farletuzumab (MORAb-003) is a monoclonal antibody which is being investigated for the treatment of ovarian cancer.This drug was developed by Morphotek, Inc.It is targeted at FR-alpha which is overexpressed in some cancers such as ovarian cancer.".